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ABSTRACT
This review found that chlorpyrifos exposure may be associated with negative impacts on
the gut microbiome, especially obesity, diabetes, and compromised immune response. Perinatal
exposure in rats was also linked to dysbiosis of intestinal microbes. Further research resulting in
primary data would be needed to substantiate the relationships. Even with a clear understanding
of the relationship, further research needs to be conducted to determine if the microbes are a
product of health outcomes or vice versa. Species-level investigation would be critical in
characterizing the true interactions of the gut. This information can be used to identify another
possible component of nutrition that fuels health disparities.
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BACKGROUND
This thesis will explore the effects of chlorpyrifos exposure through fruit and vegetable
consumption on the gut microbiome and the implicit health effects. The growing risk of climate
change has pressured society to evaluate the carbon footprint of the existing food system,
discover the high resource demands and emissions from meat production, and thus motivated a
push for plant-based diets (Schiermeier 2019). As more people buy into these diets, it is
important to consider the nuances in the nutritional profile of fruits and vegetables people will
have access to. There is evidence that residue from organophosphorus pesticides is still present
on the produce (in these studies: cucumber, apples, cabbage, eggplant, tomato, cucumber, garlic
sprouts) sold at supermarkets and is subsequently consumed if not foods are not washed and
cooked thoroughly (Liang et al., 2012, Xiao et al., 2015, Ling et al., 2011). “Round-Up Ready”
genetically modified soybeans, which are resistant to herbicides, have been found to contain high
residues of glyphosate, the most commonly used pesticide from 2008-2012 (Bohn et al., 2013,
EPA 2012). Organic produce is advertised as a means of avoiding pesticide exposure and a study
found it to be associated with significantly reduced exposure to pesticide metabolites (Bradman
2015). Even if this proves to be true, there may be health implications for low-income
populations that cannot afford the premium of organic fruits and vegetables. This systematic
review aims to investigate a few of the possible health outcomes.
It has been known for a long time that the gut microbiome plays a vital role in human
health, but the unknown still outnumbers the known. In general, bacteria, archaea, fungi, and
viruses all make up the gut ecosystem (Belizario 2018). These microorganisms play a role in
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digestion, nutrient absorption, and have recently been discovered to be involved in brain activity
that will be discussed further in the following sections. Some gut microbes may have co-evolved
with hosts to degrade otherwise toxic substances that have been ingested (Mesnage 2018). This
dynamic ecosystem of living organisms is also prone to change when foreign substances are
introduced and detrimental changes are referred to as dysbiosis. Belizario et al. define dysbiosis
generally as an “imbalance of gut’s microbial community” (Belizario 2018).

Chlorpyrifos Uses and Impacts on Health
Chlorpyrifos is a colorless, though sometimes crystalline, diethylphosphorothionate
organophosphate with a distinct, yet faint, odor that is applied most commonly in agriculture as
an insecticide and herbicide (PubChem). In pests, it acts as a neurotransmitter inhibitor,
specifically targeting acetylcholine, by binding to the enzyme cholinesterase until the high
accumulation of acetylcholine becomes toxic and kills the neuronal cells (EPA 2012).
According to the Environmental Protection Agency (EPA)’s Pesticides Industry Sales and Usage
2008-2012 report, Chlorpyrifos is the 14th most commonly used pesticide in the United States of
America in 2012 (EPA 2012). It is applied to crops such as fruits, vegetables (especially corn),
nut trees, grain crops and although not soluble in water, it can be detected in urine and blood
samples if ingested (EPA 2016, PubChem, Li et al., 2019). Diethylphosphate (DEP),
diethylthiophosphate (DETP) and 3,5,6-trichloro-2-pyridinol (TCPy) are three known
metabolites of chlorpyrifos that can also be found in urine samples and thus often serve as
biomarkers. In a human study (n=5) where volunteers ingested 1 mg of chlorpyrifos, Griffin et
al. found that nearly the entire oral dose of the pesticide would be excreted in through urine in
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the form of metabolites (Griffin et al., 1999). Another study with male human volunteers found
that chlorpyrifos had a 27-hour half-life with 70% of the dose present in their urine (Wagner et
al., 1999). In male rats, 83-87% of a 19 mg/kg body weight dose of chlorpyrifos was present in
urine and feces after 72 hours (Wagner et al., 1999).
Agency sponsored studies have found increased odds of neurological effects, such as
mental delay and attention disorders , in children who were exposed to chlorpyrifos (EPA 2016).
Rat studies by Peris-Sampedro et al. found that chlorpyrifos exposure was associated with
increased body weight and impaired memory while Joly Condette et al. observed bacterial
translocation from increased gut permeability with exposure to the pesticide (Peris-Sampedro et
al., 2015, Joly Condette et al., 2014). Organophosphates, in general, have been found to affect
the gut-brain axis, which will be defined in the next section (Roman et al. 2019). High
concentrations of chlorpyrifos in the body have also been linked to lung cancer and autoimmune
disorders (PubChem).

Gut Microbes’ Roles in Neurological Function and Mental Health
Gut microbes may impact neurological functions and mental health through an important
biochemical pathway called the gut-brain axis. As the name suggests, this connection links the
gastrointestinal tract and the central nervous system, allowing for bidirectional communication
between the two; therefore dysbiosis can result in central nervous and gastrointestinal disorders
(Carabotti et al., 2015). Some microbes produce and are even able to receive, neurotransmitters,
which can also be used to signal immune responses (Fung et al., 2017). Dempsey et al., found
that the metabolites from these microbes can alter the expression of central nervous
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system-related genes in the host via systemic circulation, influencing neuroinflammation and cell
death (Dempsey et al., 2019). Enteroendocrine cells have also been found to be involved in the
relay of sensory information from the gut, suggesting that there may be an influence on emotions
as well as eating disorders through the interactions between gut microbes and hormones (Mayer
2011). Researchers have investigated the gut microbe profile of people with existing
neurological conditions in an effort to understand possible links. A study of a Han Chinese
population diagnosed with sporadic Parkinson’s Disease, a neurodegenerative disorder, had
higher number of microbes in the following phyla: Lachnospiracea, Hydrogenoanaerobacterium,
Porphyromondaceae, Ruminococcaceae, and Verrucomicrobiaceae (Li et al., 2019).
Akkermansia muciniphila (from phylum Verrucomicrobiaceae) in particular has been found to be
positively associated with Parkinson’s Disease, multiple sclerosis in multiple studies, and autism
spectrum disorder (Jangi et al., 2016, Fang et al., 2019).

Gut Microbes’ Roles in Obesity and Diabetes
Microbe produced short-chain fatty acids (SCFA) such as propionate and butyrate play a
role in metabolism and inducing intestinal gluconeogenesis (De Vadder 2014). Chiu et al.
compiled metadata from cross-sectional studies of Taiwanese individuals’ gut microbes and
corresponding body mass index (BMI) and found the following microbial profile (at the genus
level) of people with a BMI of 24: Bacteroides (27.7%), Prevotella (19.4%), Escherichia (12%),
Phascolarctobacterium (3.9%), and Eubacterium (3.5%) (Chiu et al., 2014). People with a BMI
of 27 had the following profile: Bacteroides (29%), Prevotella (21%), Escherichia (7.4%),
Megamonas (5.1%), and Phascolarctobacterium (3.8%) (Chiu et al., 2014). A comparative
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analysis of various prospective double-blind placebo studies involving human participants found
that the Lactobacillus genus has species L. gasseri and L. plantarum have observed protective
effects against obesity through food supplements while L. acidophilus, L. ingluviei and L.
fermentum were associated with weight gain (Million et al., 2012). Broadly, several health
outcomes, including obesity, seem to be a correlation with the ratio of phyla Firmacutes to
Bacteroidetes. Yan et al. found obese rats had significantly more abundant Firmicutes and less
Bacteroidetes relative to lean rats (Yan et al., 2016).
The characteristics of microbes and their interactions, associated with obesity are similar
to those associated with diabetes as they are both metabolism-based conditions. In terms of
diabetes, microbes have been linked to low-grade inflammatory responses for cases of type 2
diabetes and insulin resistance (Everand et al., 2013). Everand et al. were able to identify
lipopolysaccharide derived from microbiota as a potential key player in the mechanism of
metabolic disease. It is also suspected that butyrate may play an important role in metabolism,
thus those bacteria that are able to produce this SCFA would prove to be beneficial against
diabetes (Qin et al., 2012).

Gut Microbes’ Roles in Other Functions
Most obviously, gut microbes play a critical role in gastrointestinal health. At the genus
level, Lactobacillus, Allobaculum, Candidatus Arthromitus, and at the family level Rikenellaceae
have been positively correlated with ileal immune response when pathogens are introduced(Cox
et al., 2014). A relatively higher Firmicute:Bacteroidetes ratio has also been associated with
inflammatory bowel disease (Rajilic-Stojanovic et al., 2011). Crohn’s disease is a specific
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inflammatory bowel disease that is associated with uncharacterized dysbiosis and relatively
lower microbiota diversity (Joossens et al., 2011).

Chlorpyrifos Exposure and Microbiota Analysis Methods
Per the acquisition criteria, all the studies administered the chlorpyrifos orally. The
dosages for their test group ranged from 0.3 mg/kg body weight to 5 mg/kg body weight through
an oil vehicle (usually corn oil) while the control groups were not given any. The test animals
received doses daily ranging of 21 days to 12 weeks. All of the studies examined in this review
were conducted on animals: rats and mice. Generally, 16S rRNA gene analysis was conducted on
fecal samples extracted from the animals after they were orally administered a set concentration
of chlorpyrifos. Fang et al., quantified the DNA by ultraviolet spectroscopy and sequenced (Fang
et al., 2018, Wang et al., 2019). Teams like Joly Condette et al., conducted species-specific
quantitative reverse transcription PCR from fecal samples as well as also extracted relevant
organs to measure anaerobic microbe cultures (Joly Condette, et al., 2015, Perez-Fernandez et
al., 2020).

METHODS
Searches were conducted using Google Scholar and PubMed. Searches included a
combination of the following terms: chlorpyrifos, pesticide, organophosphate, gut, microbiome,
microbiota, health. Significant health outcomes were identified upon initial investigation and the
following terms were added to the search: obesity, diabetes, mental health, brain axis, immune
system, digestion, Parkinson’s disease, autism, chronic fatigue, depression, multiple sclerosis,
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multiple system atrophy. The selection criteria for the studies relating to chlorpyrifos and health
are the following:
● Must specifically include chronic, oral chlorpyrifos exposure with any level of
exposure
● Any stage of life
● Microbial profile must be at Phylum level at minimum
● Test Subjects: rats and mice

To understand the possible risk of regularly consuming produce that is potentially contaminated,
it is important that the studies investigate the effects of chronic exposure. Although pesticide
exposures through produce consumption are likely small, having a variation in dosage will
provide a broader understanding of diverse eating patterns. Considering that produce
consumption is recommended for people of all ages, the review will not discriminate by stages
of life.

RESULTS
Selected Studies
Ten studies were chosen and summarized in Table 1. Three included a diet component,
comparing chlorpyrifos exposure impacts between animals receiving normal-fat and high-fat
diets, which allowed them to understand how exposure to this pesticide and possible interactions
with fat intake had impacted the gut microbiome. Fang et al. found that mice receiving
normal-fat diets and low dosages of chlorpyrifos were more likely to be associated with
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pro-obesity phenotypes and reduced serum insulin, while Li et al. found that high-fat diets
stunted the negative impacts of chlorpyrifos (Fang et al., 2018, Li et al., 2019). Four studies
included perinatal exposure; one of which, Guardia-Escote et al., only investigated postnatal
exposure.

Table 1 Selected Studies
Study

Type

Animal

Fang et al., 2018

Dose and Diet Rats, Adult

Exposure
Daily, 0.3 mg/kg(l) 3 mg/kg(h), 9 Weeks
Daily, 1 mg/kg in 1 microgram/g body
weight, 5 days postnatal

Guardia-Escote et al., 2019 Dose

Mice, Postnatal

Joly et al., 2013

Dose

Daily, 1 mg/kg body weight, 30 days;
pregnant: 1 mg/kg body weight until
Rats, Adult and Pup weaned

Joly Condette et al., 2015

Dose

Daily, Adult female: 1 or 5 mg/kg body
weight from gestation onset up to weaning;
Rats, Adult and Pup Pups received the same

Li et al., 2019

Rats, Pup (3 weeks) daily, 0.3 mg/kg for 25 weeks (baby) 20
Dose and Diet and Adult (8 weeks) weeks (adult)

Liang et al., 2019

Dose and Diet Mice, Adult

daily, 5mg/kg for 12 weeks

Reygner et al., 2016

Dose, Insulin

Rats, Pup

daily, 1 mg/kg/day (CPF1) or 3.5 mg/kg/day
(CPF3.5), 21 days

Zhao et al., 2016

Dose

Mice, Adult

daily, 1 mg/kg, 30 days

Observed Changes in Gut Microbiota from Chlorpyrifos Exposure
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The literature review found that there were four genuses of microbes that were most
studied: Bacteriodes, Bifidobacterium, Firmicutes, and Lactobacillus. The results, summarized in
Table 4 in the Appendix, were mixed. Different species within each genus responded differently
to chlorpyrifos exposure. In general, exposure to chlorpyrifos was linked to dysbiosis. In a study
looking at long-term late postnatal exposure to chlorpyrifos in mice, Perez-Fernandez et al.
observed gut dysbiosis at both the genus and species levels of the microbiota (Perez-Fernandez
2019). Table 3 summarizes the microbes that were affected by chlorpyrifos exposure and the
systems they contribute to.
There are 19 microbes that were found to have reduced abundance with the presence of
chlorpyrifos. Eight of these microbes are associated, both negatively and positively, with obesity.
Five are associated with diabetes, three are associated with neurological conditions, one is
associated with pancreatitis, and one is associated with immune system function. Nine are in the
Firmicutes phylum, making them the most represented microbes experiencing reductions (Fang
et al., 2018; Li et al., 2019; Yang et al., 2019; Zhao et al., 2016; Liang et al., 2019). There are
four microbes represented from the Bacteroidetes phylum. Four of the microbes are pathogenic
(Hydrogenoanaerobacterium, Aerococcus, Brevundimonas, Oscillibacter) , nine are beneficial
(Pseudoflavonifractor, Anaerosporobacter, Olsenella, Alloprevotella, Ruminococcus,
Clostridium_sensu_stricto_1, Paenalcaligenes, Bifidobacterium, and unspecified Bacteroidetes),
two are both pathogenic and beneficial (Akkermansia muciniphila and Firmicutes in general),
and four have functions that are not well understood (Peptococcus, Amphibacillus, Trichococcus,
Enterorhabdus).
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There were 21 microbes that were found to increase in abundance with the presence of
chlorpyrifos. Ten are associated with obesity, seven are associated with diabetes, one is
associated with the immune system function, eight are associated with neurological conditions,
four is associated with digestion, and one is associated with pancreatitis. Firmicutes represent
more than half of these microbes with thirteen microbes, while three Bacteroidetes were also
found to be enriched. Twelve of the microbes are pathogenic (Candidatus Arthromitus,
Roseburia, Coprococcus, Blautia, Acinetobactor, Pseudomonas, Sutterlla, Anaeoplasma,
Candidatus Saccharimonas, Clostridium clusters, unspecified Proteobacteria and unspecified
Verrucomicrobia), seven are beneficial (Allobaculum, Alloprevotella, Enterococcus,
Clostridium_sensu_stricto_1, Bacteroides fragilis, Ruminococcus, a nd unspecified
Bacteroidetes) , three are both pathogenic and beneficial (Bacteriodes, Lactobacillus, and
unspecified Firmicutes) and six have functions that are not well understood (Staphylococcus,
unspecified Aerobes, unspecified Actinobacteria, unspecified Cyanobacteria, unspecified
Enterobacteria, and unspecified Tenericutes).
Table 2 summarizes the implicit impact of chlorpyrifos exposure on health conditions as
it relates to the microbes. Neurological and mental health conditions as a category had no
correlation between impact and the change in abundance of corresponding microbes, while all
but Autism Spectrum disorder individually had insufficient data to determine the presence of a
correlation. No studies found any influence on anxiety-related microbes L. rhamnosus and B.
longum by chlorpyrifos. All other conditions have a negative phi coefficient, with the strongest
being microbes associated with diabetes, obesity, and the immune system.
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Table 2 Chlorpyrifos Impact and Changes in Abundance1
Condition

+/Increase

+/Decrease

-/Increase

-/Decrease

Phi Coefficient

4

2

6

3

0.00

Parkinson’s Disease

0

0

1

2

--

Autism Spectrum Disorder

2

1

5

2

-0.05

Major Depressive Disorder

1

1

0

0

--

Multiple Sclerosis

0

0

0

1

--

Chronic Fatigue Syndrome

1

1

0

0

--

Multiple System Atrophy

0

0

1

0

--

Gastrointestinal Tract

3

3

1

0

-0.35

Diabetes

2

2

4

0

-0.58

Obesity

3

5

4

0

-0.60

Immune System

0

1

1

0

-1.00

Pancreatitis

2

1

2

0

-0.41

18

17

25

8

-0.25

Neurological/Mental

TOTAL

1

+/- represents microbes with positive (+) or negative (-) health impacts. For example, +/Increase
represent microbes that have positive health impacts and experienced an increase in abundance with
exposure to chlorpyrifos
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DISCUSSION
The impacts of chlorpyrifos exposure on gut microbiota and their associated health
conditions are mixed. The true role of these microbes and the mechanisms in which they operate
are not well understood. Many studies lack the granularity needed to fully understand the
nuances within genera and even phyla. For example, Bacteriodes are a relatively well studied
genus of gut microbes and are negatively associated with glucose and lipid metabolism, obesity
and diabetes, but positively associated with multiple system atrophy and autism spectrum
disorder. It is unclear if this is characteristic of all members in this genus or if there are distinct
roles at the species level.
The phi coefficients observed in Table 2 imply that there may be a negative correlation
between positive impacts and increased abundance associated with exposure to chlorpyrifos. The
strongest relationships are observed with diabetes with a coefficient of -0.58, obesity with -0.60
and the immune system with a -1.00, though it should be noted that there were only two immune
system-related microbes affected. These negative phi coefficients align with the expectation that
the introduction of a pesticide would correlate with a decrease in beneficial microbes and an
increase in negative microbes. For diabetes, the beneficial microbes were equally found to
increase and decrease in abundance, while pathogenic microbes were only found to increase in
abundance. This would imply that chlorpyrifos’ influence on diabetes via the gut microbiome
would more likely be through pathogenic means. Obesity shares a similar relationship, though
the number of studies finding a reduction in beneficial microbes slightly outnumbers an increase
in their abundance. It is expected that these two metabolic-related conditions have the strongest
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correlation of those investigated as they are known to be critical in metabolic systems and this
role is relatively better studied. There was also a moderate negative correlation for
gastrointestinal related microbes, which is expected considering that microbes can influence
inflammation and digestion.The studies involving diet gives insight on the role that fat may play
in reducing the impacts of chlorpyrifos. Liang et al. did not observe significant impacts of diet on
microbiome changes from chlorpyrifos exposure, but Li et al. and Fang et al. did. They all found
that the exposure increased risk of obesity and insulin insensitivity (Liang et al., 2019, Fang et
al., 2018, Li et al., 2019). Joly Condette et al. found that perinatal exposure in rats was also
linked to dysbiosis of intestinal microbes (Joly Condette et al., 2015). A low
Firmicute:Bacteroidetes ratio is usually associated with weight loss in studies that investigate gut
microbe relationships with obesity, and from this compilation, it seems like chlorpyrifos aids in
that. This may be a result of limited studies that have looked at the microbes at a genus level.
Importantly, the ratio is naturally dynamic, increasing as people grow into adulthood and will
continue to change into later stages in life (Mariat et al., 2009).
Overall, the neurological and mental health conditions seem to not have any correlative
effects via the gut microbiome from chlorpyrifos exposure. Both beneficial and pathogenic
microbes were found to increase in abundance two times more than those that were found to
decrease. There is a very weak negative correlation between the positive impact and increase in
the abundance of microbes associated with Autism Spectrum Disorder. Surprisingly, no
relationship was found with Parkinson’s disease despite its relatively strong association with gut
dysbiosis in these studies.
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Limitations
The most pressing limitation of this rapid systematic review is the lack of depth
information on the microbes. Although this is likely an exhaustive list of studies examining
impacts of chlorpyrifos on the gut microbiome to date, this review lacks full coverage of all
known microbes and their functions. There is a very limited number of studies investigating the
relationship between chlorpyrifos exposure and gut microbe health in humans and thus did not
provide significant insight. Instead, all of the reviewed literature are based on rat and mice
studies so it is uncertain how accurately these interactions reflect the interactions in the human
gut. There are also limited studies on the gut microbiome in general. This limitation most likely
impacted the results observed in Table 2 and, thus, shroud the correlations in uncertainty.
Importantly, these associations cannot determine causal relationships. The chlorpyrifos was also
administered at varying degrees and stages of life for the animals. With changes in microbe
profiles as mammals age, it may make it unclear if that may be a confounding factor. The gut
microbe profile varied among rat and mice species, so when this work is translated to the human
microbiome, it would be important to consider the variation in microbial profiles of different
ethnicity and socioeconomic status. Eating trends are heavily influenced by culture and thus both
exposures and health impacts will vary.

CONCLUSION
In conclusion, there is still a great deal of research on the gut microbiome needed to
understand how it influences health outcomes. This review found that chlorpyrifos exposure may
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be associated with negative impacts on the gut microbiome, especially obesity, diabetes, and
compromised immune response. Perinatal exposure in rats was also linked to dysbiosis of
intestinal microbes. Further research resulting in primary data would be needed to substantiate
the relationships. Even with a clear understanding of the relationship, further research needs to
be conducted to determine if the microbes are a product of health outcomes or vice versa.
Species level investigation would be critical in characterizing the true interactions of the gut.
This information can be used to identify another possible component of nutrition that fuels health
disparities.
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APPENDIX
Table 3 Microbe and Associated Health Conditions
Phylum

Genus

Health Outcome

Reference
Fang et al 2018; Andoh et al

Actinobacteria

Olsenella

Diabetes, Obesity

2016
Rajilic-Stojanovicet al.,2011 and
Kerckhoffs et al.,2009; Grenham
et al., 2011; Aizawa et al., 2016;

Actinobacteria

Bifidobacterium

Digestion, Brain

Fung et. al., 2017
Frank et al., 2007; Grenham et

Actinobacteria

Digestion

al., 2011
Bercik et al., 2011; Radisavljevic

Actinobacteria

Bifidobacterium longum

Brain

et al., 2019
Joossens et al., 2011; Grenham et

Actinobacteria

Collinsella aerofaciens

Digestion

al., 2011

Diabetes, Obesity,
Bacteroidetes

Bacteriodes

Brain

Fang et al 2018
Hsiao et al., 2013; Radisavljevic

Bacteroidetes

Bacteroides fragilis

Brain

et al., 2019
Rajilic-Stojanovicet al., 2011;

Bacteroidetes

Digestion, Obesity

Grenham et al., 2011

Bacteroidetes

Alloprevotella

Pancreatitis

Fang et al 2018

Bacteroidetes

Butyricimonas

Brain

Jangi et al., 2016; Fung et al.,

24

2017
Bacteroidetes

Prevotella

Brain

?; Radisavljevic et al., 2019
Jangi et al., 2016; Fung et al.,

Euryarchaeota

Methanobrevibacter

Brain

2017
Joossens et al., 2011; Grenham et

Faecalibacterium

al., 2011; Balamurugan et al.,

Firmicutes

prausnitzii

Digestion

2009

Firmicutes

Amphibacillus

--

Fang et al 2018

Firmicutes

Trichococcus

--

Fang et al 2018

Brain, Obesity

Radisavljevic et al. 2019

Firmicutes

Malinen et al., 2005; Grenham et
Firmicutes

Lactobacillus

Digestion, Brain

al., 2011; Aizawa et al., 2016
Tomova et al., 2014; Fung et al.,

Firmicutes

Clostridium clusters

Brain

2017

Firmicutes

Candidatus Arthromitus

Brain

Fang et al 2018

Brain, Diabetes,
Firmicutes

Hydrogenoanaerobacterium Obesity

Fang et al 2018; Jung et al 2016

Firmicutes

Aerococcus

Diabetes, Obesity

Fang et al 2018

Firmicutes

Roseburia

Diabetes, Obesity

Fang et al 2018; Zhang 2013
Malinen et al., 2005 and Tana et

Firmicutes

Veillonella

Digestion

al., 2010; Grenham et al., 2011
Joossens et al., 2011; Grenham et

Firmicutes

Ruminococcus gnavus

Digestion

al., 2011

25

Joossens et al., 2011; Grenham et
Firmicutes

Ruminococcus torques

Digestion

al., 2011

Firmicutes

Oscillibacter

Obesity

Fang et al 2018; Galley 2014
Fang et al 2018; Andoh et al

Firmicutes

Coprococcus

Obesity

Firmicutes

Candidatus Saccharimonas Pancreatitis

2016
Fang et al 2018
De Angelis et al., 2013; Fung et

Firmicutes

Enterococcus

Brain

al., 2017

Clostridium_sensu_stricto_
Firmicutes

1

Diabetes, Obesity

Fang et al 2018

Firmicutes

Ruminococcus

Digestion

Fang et al 2018; Ze et al 2012
Bravo et al., 2011; Radisavljevic

Firmicutes

Lactobacillus rhamnosus

Brain

et al. 2019

Firmicutes

Pseudoflavonifractor

Obesity

Fang et al 2018; Louis et al 2016

Firmicutes

Lachnospiraceae (family)

Brain

?; Radisavljevic et al., 2019
Rajilic-Stojanovicet al.,2011;

Firmicutes

Faecalibacterium

Brain

Grenham et al., 2011

Firmicutes

Allobaculum

Pancreatitis

Fang et al 2018
Athalye-Jape et al (2016);

Firmicutes

Lactobacillus reuteri

Immune, Obesity

Million et al., 2011

Lactobacillus
Firmicutes

casei/paracasei

Obesity

Million et al., 2013

Firmicutes

Lactobacillus plantarum

Obesity

Million et al., 2013

26

Firmicutes

Clostridium difficile

Diabetes, Obesity

Goldenberg et al (2017)

Firmicutes

Blautia

Diabetes

Fang et al 2018

Firmicutes

Anaerosporobacter

Immune

Fang et al 2018

Proteobacteria

Betaproteobacteria

Brain, Diabetes

Larson et al., 2010
Tomova et al., 2014; Fung et al.,

Proteobacteria

Desulfovibrio

Brain

2017

Proteobacteria

Acinetobactor

Diabetes, Obesity

Fang et al 2018

Proteobacteria

Brevundimonas

Diabetes, Obesity

Fang et al 2018

Proteobacteria

Pseudomonas

Diabetes, Obesity

Fang et al 2018
Frank et al., 2007; Grenham et

Proteobacteria

Digestion

al., 2011
Fang et al 2018; Radisavljevic et

Proteobacteria

Sutterlla

Immune, Brain

al. 2019

Proteobacteria

Paenalcaligenes

Obesity

Li et al., 2019

Tenericutes

Anaeoplasma

Diabetes, Obesity

Fang et al 2018
Jangi et al., 2016; Fung et al.,

Verrucomicrobia

Akkermansia

Brain

2017
Everard et al., 2013;
Radisavljevic et al., 2019; Fang

Verrucomicrobia
Verrucomicrobia

Akkermansia muciniphila

Brain, Obesity

et al., 2019

Brain

Fang et al., 2019

27

Table 4 Chlorpyrifos Impact on Gut Microbe Abundance
0 = decrease, 1 = increase. Both may be indicated if multiple studies have contradicting findings.

Phylum

Genus

Role Description

Impact

Effect of

(p/n/b)

CHP

p

0

Fang et al., 2018

p

0

Reygner et al., 2016

b

1

Joly et al., 2012

p

1

Joly-Condette et al., 2014

Reference

associated with obesity
Actinobacteria

Olsenella

and diabetes
negatively associated
with irritable bowel
syndrome; negatively
associated with major
depressive disorder,

Actinobacteria

Bifidobacterium

autismi
negatively associated
with glucose and lipid
metabolism, obesity and
diabetes; positively
associated with multiple

Bacteroidetes

Bacteriodes

system atrophy, autism
could restore gut barrier
function, alter microbial
composition, and
significantly ameliorate

Bacteroidetes

Bacteroides

ASD-related behavioural

fragilis

deficits in a maternal

28

immune activation ASD
model
negatively associated
with irritable bowel
Bacteroidetes

syndrome

Zhao et al., 2016; Liang et
p

1, 0 al., 2019

negatively associated
Bacteroidetes

Alloprevotella

with pancreatitis

p

0,1 Fang et al., 2018

Firmicutes

Amphibacillus

Relatively unknown

--

0 Fang et al., 2018

Firmicutes

Trichococcus

Relatively unknown

--

0 Fang et al., 2018

negatively associated
with chronic fatigue and
positively associated with
Firmicutes

obesity, autism

Zhao et al., 2016; Liang et
b

0,1 al., 2019

probiotic, negatively
associated with irritable
bowel syndrome;
negatively associated
with major depressive
disorder, positively
Firmicutes

Firmicutes

Firmicutes

Lactobacillus

associated with autism

Clostridium

positively associated with

clusters

autism

Candidatus

positively associated with

Arthromitus

neurotoxicity and

b

1 Joly et al., 2012

n

1 Joly-Condette et al., 2014

n

1 Fang et al 2018

29

disturbed beta cell
function
positively associated with
Hydrogenoanaero obesity and diabetes and
Firmicutes

bacterium

Parkinsons

n

0 Fang et al 2018

n

0 Fang et al., 2018

n

1 Fang et al 2018

n

0 Li et al., 2019

n

1 Fang et al 2018

n

1 Fang et al 2018

associated with glucose
and lipid metabolism,
Firmicutes

Aerococcus

obesity and diabetes
positively associated with
obesity and diabetes; has
been found to be
negatively correlated

Firmicutes

Roseburia

with serum glucose
positively associated with

Firmicutes

Oscillibacter

obesity
positively associated with

Firmicutes

Firmicutes

Coprococcus

obesity

Candidatus

negatively associated

Saccharimonas

with pancreatitis
negatively associated

Firmicutes

Enterococcus

with autism

Joly et al., 2012,
p

1 Joly-Condette et al., 2014

associated with glucose
and lipid metabolism, and
Clostridium_sensu diabetes;
Firmicutes

_stricto_1

butyrate-producing

p

0,1 Fang et al., 2018

30

breaks down plant
Firmicutes

Ruminococcus

starches

p

0,1 Li et al., 2019

Pseudoflavonifract negatively associated
Firmicutes

or

with obesity

p

0 Fang et al 2018

p

1 Fang et al 2018

n

1 Fang et al 2018

p

0 Fang et al 2018

n

1 Fang et al 2018

n

0 Fang et al., 2018

n

1 Fang et al 2018

n

1 Liang et al., 2019

negatively associated
Firmicutes

Allobaculum

with pancreatitis
positively associated with
progress in the

Firmicutes

Blautia

development of diabetes
positively associated with
acetylcholine for cell

Firmicutes

Anaerosporobacter immunity
associated with glucose
and lipid metabolism,

Proteobacteria

Acinetobactor

obesity and diabetes
associated with glucose
and lipid metabolism,

Proteobacteria

Brevundimonas

obesity and diabetes
positively associated with
glucose and lipid
metabolism, obesity and

Proteobacteria

Pseudomonas

diabetes
positively associated with
inflammatory bowel

Proteobacteria

disease

31

negatively associated
with acetylcholine for
cell immunity, positively
Proteobacteria

Sutterlla

associated with autism

n

1 Fang et al 2018

p

0 Li et al., 2019

n

1 Fang et al 2018

b

0 Guardia-Escote et al., 2019

n

1 Liang et al., 2019

negative relationship with
Proteobacteria

Paenalcaligenes

high fat diet
associated with glucose
and lipid metabolism,

Tenericutes

Anaeoplasma

obesity and diabetes
protective against
obesity, positively
associated with
Parkinson's Disease,

Akkermansia
Verrucomicrobia muciniphila

autism, and multiple
sclerosis
positively associated with

Verrucomicrobia

Parkinsons
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